Introduction
Fungi are a diverse group of eukaryotic microorganisms that exist in yeast, mold, or a combination of the two forms as natural flora in humans, animals, or the surrounding environment [1, 2]. These microorganisms have diverse life cycle patterns for metabolism and cell shape adaptation, enabling them to adapt to changing ecosystems. However, it is estimated that there are between 1.5 and 5 million species of fungi; only about 72,000 species have been described, and only a few hundred of them have been mentioned as causing human disease. Some fungi, such as Blastomyces species, coccidiosis, and paracoccidioides, can cause disease in people without immune deficiency, and some fungi, which are called opportunists, such as Aspergillus, Fusarium, pseudopodium, and Candida species, mainly cause disease in people with immune system defects [3]. The genus Candida was isolated for the first time in 1844 from the sputum of a patient with tuberculosis. These fungi can metabolize glucose in aerobic and anaerobic conditions and grow at 37 °C. In addition to the environment, these fungi exist as normal flora in human and animal bodies, and their growth and reproduction are controlled by the immune system. In immune system failure, these fungi can grow on mucosal surfaces or other parts of the body and cause disease. Candida albicans (C. albicans), C. glabrata, C. tropicalis, C. parapsilosis, C. auris, C. lusitaniae, C. krusei, C. stellatoidae, C. guilliermondii, C. famata, and C. dubliniensisare the most common Candida species isolated from clinical cases [4]. C. albicans is one of the main causes of superficial infections such as oral, vaginal, skin, and nail candidiasis, as well as systemic infections such as spleen, liver, heart, kidney, central nervous system, and candidemia [3, 5]. In addition, C. albicans or other Candida species are thought to be a role in triggering or aggravating psoriasis and atopic dermatitis [6-8]. Although an increase in non-albicans species of Candida has been observed in recent years, C. albicans is still the most common cause of candidiasis, especially candidemia [5]. Epidemiological data show that the mortality rate of invasive candidiasis caused by C. albicans is still high, and despite treatment, it is reported to be close to 40% [9]. C. albicans uses several pathogenic factors such as the production of hyphae, adhesion, and invasion, secretion of hydrolase enzymes, acquisition of micronutrients, adaptation to oxygen and nitrogen deficiency, and growth at temperatures above 37 °C to cause mucosal or systemic disease [3]. This review article will investigate the pathogenic factors of C. albicans and its regulatory factors.
In this review, articles published in national and international databases such as PubMed/ MEDLINE, Google Scholar, Elsevier databases, IranMedex, Scopus, SID, and Science Direct with keywords including: “Candida” “Fungi”, “Pathogenesis,” and “virulence” were searched and related articles found during the years 1990-2022 were reviewed.
Pathogenic factors in C. albicans
Hypha (mycelium) production
Although the mycelium form of C. albicans can also be seen in the commensal state in tissue samples of patients, the predominant form of this fungus is mycelium. This phenomenon proves that the transformation of yeast into mycelium form is one of the important factors in the pathogenesis of C. albicans [3]. In addition, it has been shown that C. albicans strains that cannot produce hyphae have little pathogenic power. This indicates that hypha production plays a vital role in the effective pathogenicity of C. albicans [10]. The creation of hyphae may be effective for entering the bloodstream and creating candidemia [11]. Hyphae formation in the phagosome can help C. albicans escape phagocytosis and killing by macrophages [12]. The creation of hyphae plays a role in forming an optimal biofilm on medical devices and creating iatrogenic candidemia [13]. Host temperature, pH, and the availability of nutrients are environmental factors that play a role in changing the shape of C. albicans [14, 15]. The way yeast cells and mycelium grows is different. Mycelium growth mainly occurs in its tip, but in yeast, it mainly occurs in the bud and daughter cells and rarely in the mother cell. Unlike mycelium, which has permanent vertical growth, growth in yeasts grows vertically only at the beginning of separation from the mother cell, and then the growth becomes isotropic [16]. Cyclins are a large and diverse group of regulatory proteins in eukaryotes, each of which prefers specific substrates of the cyclin-dependent kinase (CDK) complex. The cyclin subunit determines which protein is held close to the CDK and can be converted into a substrate, while the CDK determines where the substrate is phosphorylated. Therefore, while CDKs phosphorylate proteins, cyclins determine the choice of substrate proteins and the time and place of intracellular phosphorylation [17]. Cln1 and Cln2 cyclins are expressed in the G1 phase of the cell cycle. These cyclins in the primary buds of C. albicans cause polarization of the actin filaments of the cell skeleton to the bud tip and Vertical growth by concentrating the activity of GTPase (hydrolyzing guanosine triphosphate (GTP) to guanosine diphosphate (GDP) coded by the cdc42 gene in the bud tip [17, 18]. While in the G2 phase of the cell cycle, meiotic cyclins change the vertical growth to isotropic growth by defocusing cdc42 and polarizing the actin filaments of the cell skeleton from the tip of the bud [18]. Therefore, the difference in the growth of the yeast and mycelium states of C. albicans can be attributed to the difference in the polarization of actin filaments of the cell skeleton [19]. In filamentous fungi, the placement of cell growth in a small area of the cell surface at the tip of the hyphae requires a strong polarization of the cell biosynthetic apparatus, which includes the large-scale movement of membrane-containing vesicles and cell wall precursors towards the tip of the hyphae [20, 21]. This movement depends on the cytoskeleton’s microtubule and the actin filaments and is coordinated by a vesicle organizing center (Spitzenkörper) located behind the hyphal tip [16]. Rapid exocytosis of transferred vesicles increases the length of the hyphal tip, and this exocytosis must be balanced with endocytosis to recover extra membranes and enzymes that participate in cell wall biosynthesis [22, 23]. It is thought that the mechanism of hyphal elongation in C. albicans and filamentous fungi is similar; however, important differences are seen; For example, the growth of C. albicans hyphae is relatively slower and does not seem to require microtubules [24, 25]. In addition, in the hyphae of C. albicans, the movement of most secretory vesicles takes a shorter route than filamentous fungi [26]. Like other fungi, a protein complex called polarisome forms a cap at the growth site of C. albicans hyphae and in yeast and hyphae-like cells [27]. Compared with Spitzenkörper, polarisome proteins show much less turnover [28]. Using the Bni1 protein, polarisome may stimulate actin polymerization in hyphal tips [16].
Signaling pathways controlling hyphae production
Hyphae production in C. albicans is controlled by several signaling pathways:
Cek mitogen-activated protein kinase (MAPK) pathway
This pathway is activated by factors such as nitrogen deficiency and cell wall damage [29, 30]. Membrane proteins Sho1, Opy2, and Msb2 may also play a role in Cek stimulation [31]. Cyclic adenosine monophosphate protein kinase A (cAMP-PKA) pathway
In addition to morphology, this pathway plays a role in growth, glycogen synthesis, energy metabolism, and mitochondrial activity [32-34]. This pathway is activated by environmental stimuli such as serum, N-acetyl glucose amide (GlcNAc), amino acids, and carbon dioxide [35-37]. The cellular level of cAMP is also regulated by phosphodiesterase and adenylyl cyclase [9] (Fig. 1).
Fig. 1. Signaling pathways controlling hyphae production
High-osmolarity glycerol (HOG) MAPK pathway
This pathway can control mycelium production [9]. Hog1 is activated in high osmotic pressure, and after being phosphorylated, it is transferred to the nucleus, and by affecting the glycerol transporter and changes in transcription, it prevents the transformation of yeast into mycelium [9, 38] (Fig. 1).
Tup1-mediated negative regulatory pathway
Transcription factor Tup1 is a negative regulator of mycelium production. The synergistic effect of Tup1, Nrg1, and Rfg1 has been reported. Tup1 can repress transcription, and mutants lacking Tupl can efficiently form hyphae without special induction conditions [9] (Fig. 1).
The role of pH in the regulation of hypha production
Acidic pH prevents the transformation of yeast into mycelium, while alkaline and neutral pH stimulate the production of hyphae [39, 40]. C. albicans can regulate the pH of the environment by metabolizing nutrients [9]. The Rim101 gene plays a role in transmitting the pH signal and regulating the transcription of specific pH-dependent enzymes in fungi [9, 41]. Deletion of Rim101 inhibits mycelia formed in alkaline pH. PHR1 and PHR2 genes are involved in synthesizing beta 1 and 3 glucan and beta 1 and 6 glucan and are regulated by Rim101 at different pH. PHR1 is expressed at pH less than 5.5 and PHR2 at more than 5.5 [42]. The mutant strains in PHR1 have incomplete growth in alkaline pH, and the mutant strains in PHR2 have poor growth in acidic pH [43].
Regulation of hypha elongation
Ume6, Eed1, and Hgc1 are essential in hypha elongation [44-46]. Eed1 is necessary for the expression of Ume6 and plays an important role in mycelium maintenance [46]. In mutants lacking Eed1 and Ume6, the growth in the liquid medium remains in the induction phase, and the cells cannot continue to grow. In the stable environment, these mutants grow only as yeast without mycelium production [47]. Hgc1 plays its role along with Cdc28. Mutants lacking Hgc1 can only produce very short germ tubes [48]. The expression of Hgc1 is dependent on Ume6, and Hgc1 is expressed in mutants lacking Ume6, but it cannot persist [49]. It has been shown that the phosphorylation of Cek1 MAP kinase increases in mutants lacking RAP1; Therefore, RAP1 may have an inhibitory role in hypha production [50] (Table 1).
Ability to adhere and form a biofilm
After the production of hyphae, the ability to adhere and form a biofilm is among the most important Virulence factors of C. albicans [9]. Attachment helps the organism to persist in the host and is, therefore, necessary for the spread and settlement of the fungus [51]. It is estimated that biofilm formation is related to 65 to 80% of microbial infections [52, 53]. 80% of C. albicans infections are directly or indirectly related to biofilm formation [54]. The production of hyphae and the ability to adhere together with the secretion of proteases and phospholipases facilitate the invasion of the fungus into epithelial cells [51]. C. albicans have a set of proteins that bind it to host cells, non-living surfaces, and other microorganisms, and biofilm formation [55, 56]. Adhesive molecules called Als (agglutinin-like sequence) have been studied more than others. These proteins form a family with eight members, Als1-7 and Als9 [57]. Als1 is important in binding to epithelial, endothelial cells, and biological surfaces [9, 51]. It has been shown that increasing the expression of this molecule causes a 125% increase in binding [9]. It has been shown that Als3 plays an important role in endocytosis and invasion of host tissues [58-60]. Only Als1 and Als5 in Al’s family have the same function as Als3 [61]. Strains lacking Als5, Als6, or Als7 have normal binding power but slower growth [62]. Als2, Als4, and Als9 have not been investigated in the laboratory [9]. Hwp1 is another adhesive molecule that plays an important role in the attachment of C. albicans to host cells [54]. A synergistic effect for Als1 and Hwp1 has been reported for germ tube formation, an essential step for fungal pathogenesis [62]. It has been shown that the mutants lacking this adhesive molecule show less binding power to oral epithelial cells and also less pathogenic power in systemic candidiasis in mice [57]. Hwp1 does not seem to have a role in binding to endothelial cells [51]. Hwp1 and Als3 cooperate in the formation of biofilm [63].
The regulation of adherence and biofilm formation
Bcr1 plays an important role in regulating C. albicans hyphae adhesion molecules [64]. (Table 1, Fig. 2). Als3 is a key target for Bcr1 action [65]. Hwp1, which is an epithelial adhesion molecule, is also controlled by Bcr1. Mutants lacking Bcr1 cannot form a significant biofilm in the tongue of immunodeficient mice due to defects in adherence [66]. The Efg1 gene, which plays an essential role in hypha production, also plays a role in C. albicans attachment [61]. This gene’s expression is influenced by the immune system. Mutants lacking Efg1 have defects in cell layer formation on polystyrene surfaces due to changes in surface protein composition. In addition, the lack of Efg1 function in some C. albicans strains, only the formation of pseudohyphae in solid medium and no growth in liquid medium are observed. Ywp1 is also expressed only at the end of the logarithmic phase of yeast sols and is not found in pseudohyphae and mycelium. Yeasts with Ywp1 form only one cell layer, while mutants lacking this gene can connect and form biofilm. Therefore, it seems that Ywp1 has an inhibitory role in the attachment and formation of biofilm. Sfp1 is another gene that plays an inhibitory role in the binding of C. albicans [65]. Increased expression of Als1, Als3, and Hwp1 and, as a result, increased binding strength is observed in mutants lacking Sfp1. Increasing the expression of Sfp1 also decreases the expression of adhesive molecules. Sfp1 may exert its role through Bcr1 and Efg1 and the Rhb1-Tor1 signaling pathway [67]. CaFEN1 and CaFEN12 are also involved in adhesion and biofilm formation through the synthesis of sphingolipids, and the deletion of these genes inhibits biofilm formation [65]. It seems that RAP1 has an inhibitory role in biofilm formation. It has been shown that mutants lacking RAP1 form a stronger biofilm than C. albicans having this factor [50].
Hydrolase enzymes
Hydrolase enzymes such as: Proteases secreted aspartyl proteinases (SAPs), lipases (LIPs) and phospholipases (PLBs) play a role in providing nutrients for C. albicans through protein degradation, facilitating penetration and invasion of host tissues and also evading immune responses [68, 69]. Among the hydrolase enzymes, SAPs have been studied more deeply. C. albicans have 10 genes (SAP1-SAP10) encoding this enzyme, which plays an important role in the pathogenesis of this fungus [68]. It has been shown that SAP1,2,3 are involved in tissue damage during superficial infection, and SAP4,5,6 are involved in tissue damage during systemic infection [70]. SAPs are also used in diagnosing systemic candidiasis by the enzyme-linked immunosorbent assay method [71]. The key advantage of using SAPs is their ability to differentiate colonization from invasive disease [68].
Table 1. Pathogenic factors of Candida albicans and its regulatory genes
Number |
Pathogenic factor |
Regulatory genes |
1 |
Mycelium production |
Ume6،Eed1 ، Hgc1،Rap1 |
2 |
Adherence and formation of biofilm |
Bcr1، Efg1،CaFEN1 ،CaFEN12, Ywp1،Sfp1 ،Rap1 |
3 |
hydrolase enzymes |
Cph1، Efg1، Tec1، Hog1
Tup1،Mig1 ،Nrg1 |
4 |
Absorption of micronutrients |
ZRT1-3 ، ZRC1، Sef1،Sfu1 ،CRD1 |
5 |
Compatibility with different levels of oxygen |
Ofd1، Nrg1،Ume6 |
6 |
Growth in nitrogen deficiency conditions |
MEP1 ،MEP2،Ume6 ،Brg1 |
7 |
Growth at a temperature higher than 37 °C |
Hms1 ،Hsf1 |
Fig. 2. Candida albicans biofilm gene regulation network
SAP2 can be used to make a vaccine to prevent systemic candidiasis in BALB/c mice [72]. It has been shown that using SAP2 protein conjugated with alum adjuvant has brought efficient immune protection with a 20-fold reduction in kidney colonization [68]. The products of SAP1-8 genes are secreted in the intercellular space, and the products of SAP9,10 genes are attached to the cell wall [73]. Phospholipases are other enzymes that have four classes of PLBA-D [74]. However, probably only five members of (PLB1-5) are involved in the pathogenesis of C. albicans. The expression of phospholipase B has been observed in mucosal, digestive, and systemic infections [75]. Most of the activity of phospholipase B is related to Plb1, and Plb2 has little activity [76]. The lipase family is another enzyme comprising 10 members [LIP1-10] [68]. The expression of LIP5,6,8,9 has been observed in induced peritonitis in mice [77]. It has been reported that the lack of LIP8 expression reduced the pathogenicity of C. albicans in mice [78]. Lipase increases the secretion of pro-inflammatory cytokine Interleukin-6 and decreases the secretion of anti-inflammatory cytokine transforming growth factor; therefore, lipase seems to play a role in pathogenesis by causing inflammation [79].
Regulation of hydrolysis enzymes
SAP gene expression depends on other pathogenic factors, such as mycelium production and phenotype change. In addition, pH, type, stage of infection, and substrate availability are effective in the expression and regulation of SAP genes [80]. Biofilm formation is also effective in regulating the expression of SAP genes; in this way, SAP5,6,9 are seen more in biofilm than in planktonic growth [81]. Transcription factors Cph1 and Efg1 of the MAP kinase pathway and the cAMP pathway regulate the production of hyphae and the expression of SAP4-6 [81, 82]. In addition, it seems that Efg1 also regulates mycelium-independent SAP genes because deletion of Efg1 decreases the expression of yeast-specific SAP1 and SAP3 proteinases [83]. Transcription factor Tec1, which is often expressed during mycelium production, It is involved in the expression of SAP4–6 [84]. The transcription factor Nrg1, which Tup1 regulates, can prevent the expression of SAP5. Tup1 also regulates transcription factor Mig1 and can prevent the expression of SAP9. In addition, the transcription factor Tup1 can inhibit the expression of SAP6,7 independently of Mig1 and Nrg1 [85]. Therefore, it seems that Efg1, Cph1, and Tec1 stimulate the expression of SAPs, and Tup1, Mig1, and Nrg1 prevent the expression of SAPs [80]. The expression of lipases and PLB1 can be influenced by environmental conditions such as temperature, pH, and nutrients. The expression of PLB1 is controlled by the transcriptional inhibitory factor Tup1. Increased expression of PLB1 has been observed in mutants lacking Tup1 [86]. The hog1 protein kinase signal transduction pathway is also effective in PLB1 expression. Mutations in Hog1 decrease PLB1 expression [87].
Absorption of micronutrients
The absorption of micronutrients by C. albicans plays an important role in the pathogenesis of this fungus [88]. The concentration of iron, zinc, and copper in people is very variable and is influenced by factors such as diet, gender, age, general health, and lifestyle [88-90]. To reduce the growth of microbial agents, the host’s body tries to keep nutrients away from them. To neutralize such defense and survive in the host’s body, C. albicans expresses and regulates several micronutrient acquisition systems [88].
- Zinc absorption
C. albicans can absorb free zinc in the environment, and zinc bound to host proteins by pH-dependent antigen-1 (Pra1p) [91]. Sap6p can also provide this micronutrient for the fungus by binding to zinc in low-zinc environments [92]. Zinc homeostasis in C. albicans is regulated by a transcriptional activator called Zap1p, which controls the expression of several genes, including zinc transporters ZRT1-3 and ZRC1 [93, 94]. (Table 1)
- Iron absorption
Iron, as a cofactor in metabolic functions, is needed for the survival of most organisms [95]. In addition, iron is also effective in mycelium production and the pathogenicity of C. albicans [96]. Since iron does not exist in free form in the body, pathogenic microorganisms have developed complex strategies to obtain this element [95]. C. albicans use three systems for iron absorption: hemoglobin absorption, reduced iron absorption, and siderophore collection [88]. Ferric reductases Cfl1p and Fre10p regenerate Fe3+ in transferrin to Fe2+ [97, 98]. Then the reduced iron is transported into the cell through permeases Ftr1p, Ftr2p, Fth1p, and Fth2p [99, 100]. C. albicans use siderophore transfer protein [Sit1p] to absorb iron from other bacteria and fungi [88]. For survival and successful invasion, C. albicans must be able to absorb iron from environments with different concentrations. The concentration of iron in the gastrointestinal tract is high, and in the blood and tissue is low. Iron absorption is controlled by two transcription factors, Sef1 and Sfu1. Sef1 is responsible for increasing iron absorption in environments with low concentrations. Iron absorption pathways are suppressed in environments with high iron [101].
Under high iron conditions, phosphorylated Sfu1 binds to the Sef1 promoter in the nucleus and inhibits transcription, and binds to the Sef1 protein in the cytosol, preparing Sef1 for degradation. As iron concentration decreases, Sef1 is phosphorylated and prevents Sfu1 binding. Then, Sef1-P can enter the nucleus and induce the transcription of genes for the absorption and utilization of iron [102] (Table 1).
- Copper absorption
Copper is needed for the effective absorption of iron and also the function of proteins [88]. C. albicans stimulate the expression of copper transporter (Ctr1p) by using the Mac1p transcription factor [103, 104]. Mutants lacking Ctr1 cannot grow in conditions of iron and copper deficiency [103]. Increasing copper concentration can create toxic conditions for C. albicans; therefore, this fungus activates the P1-type ATPase copper pump and removes excess copper from the cell by expressing the CRD1 gene [88]. Mutants lacking CRD1 are sensitive to external sources of copper, silver, and cadmium [103]. Sur7p plays a role in morphogenesis, cell wall synthesis, actin polymerization, and cell wall resistance against stresses [105-108]. It has been shown that the deletion of Sur7 increases sensitivity to copper [109] (Table 1).
Compatibility with different levels of oxygen
Adaptation to different oxygen levels is essential for the formation of hyphae and pathogenicity of C. albicans. Transcription factor Ume6p increases the length of hyphae in hypoxic conditions in combination with 5% CO2. On the other hand, hypoxia with 5% CO2 decreases the expression of NRG1, which is a negative regulator of hypha formation [110]. Ofd1p, part of the 2-oxoglutarate and Fe2+-dependent dioxygenases (2-OGDD) enzyme pathway, plays a role in hypha induction in hypoxic conditions. Ofd1p acts as an oxygen sensor through Ume6p. Ofd1p consists of two components, Ofd1N and Ofd1C. Ofd1C induces the degradation of Ume6p in high oxygen conditions, and Ofd1N, by inhibiting Ofd1C in low oxygen conditions, causes the continuation of Ume6p activity and the increase in hyphae length [111].
Growth in nitrogen deficiency conditions
Nitrogen deficiency can cause the transformation of yeast into hyphae [110]. Two ammonium permease genes, MEP1 and MEP2, are expressed in nitrogen deficiency conditions and allow growth. These genes cause the activation of signal transmission pathways and, as a result, mycelium production [112]. The Tor1 pathway also responds by regulating Brg1p and Ume6p in nitrogen deficiency conditions. This pathway is a negative regulator of mycelium production. Inhibition of this pathway causes mycelium production by activating Brg1p and preventing the activity of Nrg1p-Tup1p [110]. RHB1 is another transcription factor that plays a role in stimulating hypha production through MEP2 under nitrogen deficiency conditions [113-115].
Growth at a temperature higher than 37 °C
C. albicans usually produce mycelium at 37-39 °C [110]. At high temperatures, the inhibition of Ras1p by Hsp90p decreases, which leads to an increase in Ras1GTPase activity. Then Ras1p stimulates cAMP production by Cyr1p, and finally, the cAMP-PKA pathway is activated to induce mycelium. Hsp90p appears to suppress mycelium production mainly through the cAMP-PKA signaling pathway, as any disruption of the upstream components of the cAMP-PKA pathway that blocks PKA-dependent signaling prevents the induction of hyphal growth [116]. It has been shown that the genetic deletion of Hsp90p reduces the severity of systemic disease in mice [110]. At high temperatures, Hsp90p regulates mycelium production through the transcription factors Hms1p and Hsf1p, independent of the cAMP-PKA pathway [117, 118].
Conclusion
C. albican’s pathogenicity is a multifactorial process regulated by a network of pathogenic factors. Knowledge of the pathogenic factors of this fungus provides the possibility of developing better diagnosis and treatment methods for infected people. Shape change seems an important phenomenon in pathogenesis; therefore, it is necessary to carefully study the environmental signals and intestinal metabolites that can play a role
in this shape change. Knowing how to modify these signals can effectively control commensalism and prevent pathogenicity. Targeting the transformation may also be effective in infection control and treatment. Targeting other pathogenic factors, such as the secretion of hydrolase enzymes and the expression of adhesive molecules, may be a successful strategy in controlling and treating infection; of course, there are many ambiguous points about hydrolase enzymes; for example, the exact role of Sap9 and Sap10 remains unknown. The information about the secreted phospholipases also has fewer details than the SAP family. Lipases secreted by C. albicans have also received less attention, with many ambiguous points about them. The interaction between host nutrients and the nutrient absorption systems of fungi can be studied. Interference in iron, zinc, copper, oxygen, and nitrogen homeostasis systems may be a suitable therapeutic strategy.
Conflict of Interest
The authors declare that there is no conflict of interest.
Acknowledgment
None.
References
[1]. Kamali M, Taheri Sarvtin MA. survey on airborne fungal spores in indoor air and outdoor air of Babol city. Journal of Jiroft University of Medical Sciences 2015; 2(1): 116-30.
[2]. Taheri Sarvtin M, Kamali M, Yazdani J. A review on the risk factors, presentations and treatment of candidemia. Journal of Jiroft University of Medical Sciences 2015; 2(2): 55-60.
[3]. Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence 2022; 13(1): 89-121.
[4]. Taheri Sarvtin M, Hedayati MT, Ayatollahi Mosavi SA, Afsarian MH. An overview on the role of microbial agents in psoriasis. Mazand Univ Med Sci. 23(98): 364-85.
[5]. Arita GS, Conrado PCV, Sakita KM, Rodrigues-Vendramini FAV, Faria DR, Kioshima ES, et al. Serial systemic candidiasis alters Candida albicans macromorphology associated with enhancement of virulence attributes. Microb Pathog. 2022; 164: 105413.
[6]. Taheri Sarvtin M, Shokohi T, Hajheydari Z, Yazdani J, Hedayati MT. Evaluation of candidal colonization and specific humoral responses against Candida albicans in patients with psoriasis. International Journal of Dermatology 2014; 53(12): 555-60.[7]. Taheri Sarvtin M, Hajheydari Z, Hedayati MT. A Review on the role of fungi in atopic dermatitis. Journal of Mazandarn University of Medical Sciences. 2012; 22(87): 115-37.
[8]. Taheri Sarvtin M, Hedayati MT, Abastabar M, Shokohi T. Debaryomyces hansenii colonization and its protein profile in psoriasis. Iranian Journal of Dermatology 2014; 17(4): 134-37.
[9]. Hui Chen, Xuedong Zhou, Biao Ren, Lei Cheng. The regulation of hyphae growth in Candida albicans.Virulence 2020; 11(1): 337-48.
[10]. Murad AM. Munir A, Leng P, Straffon M, Wishart J, Macaskill S, et al. NRG1 represses yeast–hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO. 2001; 20(17): 4742-752.
[11]. Koh AY, Köhler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS pathog. 2008; 4(2): e35.
[12]. McKenzie CG, Koser U, Lewis LE, Bain JM, Mora-Montes HM, Barker RN, et al. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect Immun. 2010; 78 (4): 1650-658.
[13]. Nobile CJ, Johnson AD. Candida albicans biofilms and human disease. Annu Rev Microbiol. 2015; 69: 71-92.
[14]. Lu Y, Su C, Liu H. Candida albicans hyphal initiation and elongation. Trends Microbiol. 2014; 22 (12): 707-14.
[15]. Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, Lorenz MC. The fungal pathogen Candida albicans autoinduces hyphal morpho-genesis by raising extracellular pH. mBio. 2011; 2 (3): 55-61.
[16]. Kornitzer D. Regulation of Candida albicans hyphal morphogenesis by endogenous signals. Fungi (Basel). 2019; 5(1): 21.
[17]. Srivastava LM. Cell wall, cell division, and cell growth. Chapter 2. In: Plant Growth and Development; 2002. p. 23-74.
[18]. Chiou JG, Balasubramanian MK, Lew DJ. Cell polarity in yeast. Annu Rev Cell Dev Biol. 2017; 33(1): 77-101.
[19]. Liu H. Transcriptional control of dimorphism in Candida albicans. Curr Opin Microbiol. 2001; 4(6): 728-35.
[20]. Steinberg G, Peñalva MA, Riquelme M, Wösten HA, Harris SD. Cell Biology of Hyphal Growth. Microbiol. Spectr. 2017; 5(2): 1-34.
[21]. Riquelme M, Aguirre J, Bartnicki-García S, Braus GH, Feldbrügge M, Fleig U, et al. Fungal morphogenesis, from the polarized growth of hyphae to complex reproduction and infection structures. Microbiol Mol Biol Rev. 2018; 82(2): e00068-17.
[22]. Bartnicki-Garcia S, Garduño-Rosales M, Delgado-Alvarez DL, Mouriño-Pérez RR. Experimental measurement of endocytosis in fungal hyphae. Fungal Genet Biol. 2018; 118: 32-6.
[23]. Hernández-González M, Bravo-Plaza I, Pinar M, de Los Ríos V, Arst HN, Peñalva MA. Endocytic recycling via the TGN underlies the polarized hyphal mode of life. PLoS Genet. 2018; 14(4): e1007291.
[24]. Yokoyama K, Kaji H, Nishimura K, Miyaji M. The role of microfilaments and microtubules in apical growth and dimorphism of Candida albicans. J Gen Microbiol. 1990; 136(6): 1067-1075.
[25]. Rida PCG, Nishikawa A,Won GY, Dean N. Yeast-to-hyphal transition triggers formin-dependent golgi localization to the growing tip in Candida albicans. Mol Biol Cell. 2006; 17(10): 4364-378.
[26]. Weiner A, Orange F, Lacas-Gervais S, Rechav K, Ghugtyal V, Bassilana M, et al. On-site secretory vesicle delivery drives filamentous growth in the fungal pathogen Candida albicans. Cell Microbiol. 2019; 21(1): 12963.
[27]. Crampin H, Finley K, Gerami-Nejad M, Court H, Gale C, Berman J, et al. Candida albicans hyphae have a Spitzenkörper that is distinct from the polarisome found in yeast and pseudohyphae. J Cell Sci. 2005; 118(Pt 13): 2935-947.
[28]. Jones LA, Sudbery PE. Spitzenkörper, exocyst, and polarisome components in Candida albicans hyphae show different patterns of localization and have distinct dynamic properties. Eukaryot Cell 2010; 9(10): 1455-465.
[29]. Cheetham J, Smith DA, da Silva Dantas A, Doris KS, Patterson MJ, Bruce CR, et al. A single MAPKKK regulates the Hog1 MAPK pathway in the pathogenic fungus Candida albicans. Mol Biol Cell. 2007; 18(11): 4603-614.
[30]. Roman E, Alonso-Monge R, Gong Q, Li D, Calderone R, Pla J. The Cek1 MAPK is a short-lived protein regulated by quorum sensing in the fungal pathogen Candida albicans. FEMS Yeast Res. 2009; 9(6): 942-55.
[31]. Herrero-de-Dios C, Alonso-Monge R, Pla J. The lack of upstream elements of the Cek1 and Hog1 mediated pathways leads to a synthetic lethal phenotype upon osmotic stress in Candida albicans. Fungal Genet Biol. 2014; 69: 31-42.
[32]. Giacometti R, Kronberg F, Biondi RM, Passeron S. Catalytic isoforms Tpk1 and Tpk2 of Candida albicans PKA have non-redundant roles in stress response and glycogen storage. Yeast 2009; 26(5): 273-85.
[33]. Sun W, Zhang L, Lu X, Feng L, Sun S. The synergistic antifungal effects of sodium phenylbutyrate combined with azoles against Candida albicans via the regulation of the Ras– cAMP–PKA signalling pathway and virulence. Can J Microbiol. 2019; 65(2): 105-15.
[34]. Lin CJ, Chen YL. Conserved and divergent functions of the cAMP/PKA signaling pathway in Candida albicans and Candida tropicalis. J Fungi (Basel). 2018; 4(2): 68.
[35]. Grahl N, Demers EG, Lindsay AK, Harty CE, Willger SD, Piispanen AE, et al. Mitochondrial activity and Cyr1 are key regulators of Ras1 activation of C. albicans virulence pathways. PLoS Pathog. 2015; 11(8): 1005133
[36]. Klengel T, Liang WJ, Chaloupka J, Ruoff C, Schröppel K, Naglik JR, et al. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr Biol. 2005; 15(22): 2021-2026.
[37]. Xu XL, Lee RTH, Fang HM, Wang, YM, Li R, Zou H, et al. Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe. 2008; 4(1): 28-39.
[38]. Nadal Clanchet ED, Posas Garriga F. The HOG pathway and the regulation of osmoadaptive responses in yeast. FEMS Yeast Res. 2022; 22 (1): 13.[39]. Biswas S, Van Dijck P, Datta A. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev. 2007; 71(2): 348-76.
[40]. Davis D. Adaptation to environmental pH in Candida albicans and its relation to pathogenesis. Curr Genet. 2003; 44(1): 1-7.
[41]. Aréchiga-Carvajal ET, Ruiz-Herrera J. The RIM101/ pacC homologue from the basidiomycete Ustilago maydis is functional in multiple pH-sensitive phenomena. Eukaryot Cell. 2005; 4(6): 999-1008.
[42]. Davis D, Wilson RB, Mitchell AP. RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol. 2000; 20(3): 971-78.
[43]. Li M, Martin SJ, Bruno VM, Mitchell AP, Davis, DA. Candida albicans Rim13p, a protease required for Rim101p processing at acidic and alkaline pHs. Eukaryot Cell. 2004; 3(3): 741-51.
[44]. Mendelsohn S, Pinsky M, Weissman Z, Kornitzer D. Regulation of the Candida albicans hypha-inducing transcription factor Ume6 by the CDK1 cyclins Cln3 and Hgc1. mSphere 2017; 2(2): 248-16.
[45]. Banerjee M, Uppuluri P, Zhao XR, Carlisle, P. L., Vipulanandan G, Villar CC, et al. Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1and Sun41-dependent mechanisms. Eukaryot Cell 2013; 12(2): 224-32.
[46]. Martin R, Moran GP, Jacobsen ID, Heyken A, Domey J, Sullivan DJ, et al. The Candida albicans-specific gene EED1 encodes a key regulator of hyphal extension. PLoS One 2011; 6(4): 18394.
[47]. Childers DS, Kadosh D, Sturtevant J. Filament condition-specific response elements control the expression of NRG1 and UME6, key transcriptional regulators of morphology and virulence in Candida albicans. PLoS One 2015; 10(3): 122775.
[48]. Wang Y. Hgc1-Cdc28-how much does a single protein kinase do in the regulation of hyphal development in Candida albicans? J Microbiol. 2016; 54(3): 170-77.
[49]. Carlisle PL, Kadosh D. Candida albicans Ume6, a filament-specific transcriptional regulator, directs hyphal growth via a pathway involving Hgc1 cyclin-related protein. Eukaryot Cell 2010; 9(9): 1320-328.
[50]. Wang WH, Lai TX, Wu YC, Chen ZT, Tseng KY, Lan CY. Associations of Rap1 with cell wall integrity, biofilm formation, and virulence in Candida albicans. Microbiol Spectr. 2022; 10(6): 328522.[51]. Maras B, Maggiore A, Mignogna G, D’Erme M, Angiolella L. Hyperexpression of CDRs and HWP1 genes negatively impacts on Candida albicans virulence. Plos One 2021; 16(6): 252555.
[52]. Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, et al. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018; 81 (1): 7-11.
[53]. Van Acker H, Van Dijck P, Coenye T. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol. 2014; 22(6): 326-33.
[54]. Fanning S, Mitchell AP. Fungal biofilms. PLoS Pathog 2012; 8(4): 1002585.
[55]. Garcia MC, Lee JT, Ramsook CB, Alsteens D, Dufrêne YF, Lipke PN. A role for amyloid in cell aggregation and biofilm formation. PLoS One 2011; 6(3): 17632.
[56]. Verstrepen KJ, Klis FM. Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol. 2006;60(1): 5-15.
[57]. Mayer FL., Wilson D, Hube B. Candida albicans pathogenicity mechanisms.Virulence 2013; 4(2): 119-28.
[58]. Mushi MF, Bader O, Taverne-Ghadwal L, Bii C, Groß U, Mshana SE. Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa. J Oral Microbiol. 2017; 9(1): 1317579.
[59]. Mackenzie A, Marshall NW, Hadjipanteli A, Dance DR, Bosmans H, Young KC. Characterisation of noise and sharpness of images from four digital breast tomosynthesis systems for simulation of images for virtual clinical trials. Phys Med Biol. 2017; 62(6): 2376-397.
[60]. Kullberg BJ, Vasquez J, Mootsikapun P, Nucci M, Paiva JA, Garbino J, et al. Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials. J Antimicrob Chemother. 2017; 72(8): 2368-377.
[61]. Zhao X, Oh SH, Hoyer LL. Deletion of ALS5, ALS6 or ALS7 increases adhesion of Candida albicans to human vascular endothelial and buccal epithelial cells. Med Mycol. 2007; 45(5): 429-34.
[62]. Nas T, Kalkanci A, Fidan I, Hizel K, Bolat S, Yolbakan S, et al. Expression of ALS1, HWP1 and SAP4 genes in Candida albicans strains isolated from women with vaginitis. Folia Microbiol (Praha). 2008; 53(2): 179-83.
[63]. Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, et al. Complementary adhesion function in C. albicans biofilm formation. Curr Biol. 2008; 18(14): 1017-1024.
[64]. Nobile C, Mitchell AP. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol. 2005; 15(12): 1150-155.
[65]. Xu Z, Huang T, Du M, Soteyome T, Lan H, Hong W, et al. Regulatory network controls microbial biofilm development, with Candida albicans as a representative: From adhesion to dispersal. Bioengineered 2022; 13(1): 253-267.
[66]. Dwivedi P , Thompson A, Xie Z, Kashleva H, Ganguly S, Mitchell AP, et al. Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLoS One 2011; 6(1): 16218.
[67]. Chen HF, Lan CY, Coste AT. Role of SFP1 in the regulation of Candida albicans biofilm formation. PLoS One 2015; 10(6): 129903.
[68]. Chin VK, Lee TY, Rusliza B, Chong PP. Dissecting Candida albicans infection from the perspective of C. albicans virulence and omics approaches on host–pathogen interaction: a review. Int J Mol Sci. 2016; 17(10): 1643.
[69]. de Barros PP, Rossoni RD, De Camargo Ribeiro F, Junqueira JC, Jorge AOC. Temporal profile of biofilm formation, gene expression and virulence analysis in Candida albicans strains. Mycopathologia 2017; 182(3-4): 285-95.
[70]. Costa CR, Jesuíno RSA, de Aquino Lemos J, de Fátima Lisboa Fernandes O, Hasimoto e Souza LK, Passos XS, et al. Effects of antifungal agents in sap activity of Candida albicans isolates. Mycopathologia 2010; 169(2): 91-8.
[71]. Morrison CJ, Hurst SF, Reiss E. Competitive binding inhibition enzyme-linked immuno-sorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin Diagn Lab Immunol. 2003; 10(5): 835-48.
[72]. Vilanova M, Teixeira L, Caramalho Í, Torrado E, Marques A, Madureira P, et al. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase. Immunology 2004; 111(3): 334-42.
[73]. Ilkhanizadeh-Qomi M, Nejatbakhsh S, Jahanshiri Z, Razzaghi-Abyaneh M. Aspartyl proteinase and phospholipase activities of candida albicans isolated from oropharyngeal candidiasis in head and neck cancer patients. Journal of Jiroft University of Medical Sciences. 2022; 13(9): 105200.
[74]. Niewerth M, Korting HC. Phospholipases of Candida albicans. Mycoses 2001; 44(9-10): 361-77.
[75]. Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48(6): 365-77.
[76]. Ilkhanizadeh-Qomi M, Nejatbakhsh S, Jahanshiri Z, Razzaghi-Abyaneh M. Aspartyl proteinase and phospholipase activities of candida albicans isolated from oropharyngeal candidiasis in head and neck cancer patients. Journal of Jiroft University of Medical Sciences 2020; 13(9): e105200.
[77]. Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M, Schäfer W. Secreted lipases of Candida albicans: Cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol. 2000; 174(5): 362-74.
[78]. Gácser A, Stehr F, Kröger C, Kredics L, Schäfer W, Nosanchuk JD. Lipase 8 affects the pathogenesis of Candida albicans. Infect Immun. 2007; 75(10): 4710-718.
[79]. Castillo GDV, Aguilar JD, Miró MS, Sotomayor C, Azcurra AI. Role of C. albicans LIP in isolates from malignant lesions on in vitro model of human buccal cells. FO-Congresos; 2017 Nov; Curitiba; Brasil. Available at: http://hdl.handle.net/ 11086/29026
[80]. Naglik J, Albrecht A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol. 2004; 6(10): 915-26.
[81]. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d’Enfert C. C. albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 2004; 3(2): 536-45.
[82]. Naglik JR, Moyes D, Makwana J, Kanzaria P, Tsichlaki E, Weindl G, et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 2008; 154(11): 3266-280.
[83]. Korting H, Hube B, Oberbauer S, Januschke E, Hamm G, Albrecht A, et al. Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. J Med Microbiol. 2003; 52(Pt 8): 623-32.
[84]. Schweizer A, Rupp S, Taylor BN, Röllinghoff M, Schröppel K. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol. 2000; 38(3): 435-45.
[85]. Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, et al. NRG1 represses yeasthypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO. 2001; 20(17): 4742-752.
[86]. Hruskova-Heidingsfeldova O. Secreted proteins of Candida albicans. Front Biosci Landmark 2008; 13(18): 7227-242.
[87]. Enjalbert B, Smith DA, Cornell MJ, Alam I, Nicholls S, Brown AJ, et al. Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. Mol Biol Cell. 2006; 17(2): 1018-1032.[88]. Nikou SA, Kichik N, Brown R, Ponde NO, Ho J, Naglik JR, et al. Candida albicans interactions with mucosal surfaces during health and disease. Pathogens 2019; 8(2): 53[89]. Kode MA, Karjodkar FR. Estimation of the serum and the salivary trace elements in OSMF patients. J Clin Diagn Res. 2013; 7(6): 1215-218.
[90]. Kim YJ, Kim YK, Kho HS. Effects of smoking on trace metal levels in saliva. Oral Dis. 2010; 16(8): 823-30.
[91]. Citiulo F, Jacobsen ID, Miramon P, Schild L, Brunke S, Zipfel P, et al. Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog. 2012; 8(6): e1002777
[92]. Kumar R, Breindel C, Saraswat D, Cullen PJ, Edgerton M. Candida albicans Sap6 amyloid regions function in cellular aggregation and zinc binding, and contribute to zinc acquisition. Sci Rep. 2017; 7(1): 2908.
[93]. Kim MJ, Kil M, Jung JH, Kim J. Roles of zinc-responsive transcription factor Csr1 in filamentous growth of the pathogenic yeast Candida albicans. J Microbiol Biotechnol. 2008; 18(2): 242-47.
[94]. Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 2009; 7(6): e1000133.
[95]. Lan CY, Rodarte G, Murillo LA, Jones T, Davis RW, Dungan J, et al. Regulatory networks affected by iron availability in Candida albicans. Mol Microbiol. 2004; 53(5): 1451-469.
[96]. Junier A, Weeks A, Alcaraz Y, Kumamoto CA. Bypass of Dfi1 regulation of Candida albicans invasive filamentation by Iron Limitation. mSphere 2022; 7(1): e0077921.
[97]. Knight S, Vilaire G, Lesuisse E, Dancis A. Iron acquisition from transferrin by Candida albicans depends on the reductive pathway. Infect Immun. 2005; 73(9): 5482-492.
[98]. Hammacott JE, Williams PH, Cashmore AM. Candida albicans Cfl1 encodes a functional ferric reductase activity that can rescue a Saccharomyces cerevisiae fre1 mutant. Microbiology 2000: 146 (Pt 4): 869–876
[99]. Ramanan N, Wang Y. A high-anity iron permease essential for Candida albicans virulence. Science 2000; 288(5468): 1062-1064.
[100]. Mamouei Z, Zeng G, Wang YM, Wang Y. Candida albicans possess a highly versatile and dynamic high-a_nity iron transport system important for its commensal-pathogenic lifestyle. Mol Microbiol. 2017; 106(6): 986-98.[101]. Chen C, Pande K, French SD, Tuch BB, Noble SM. An iron homeostasis regulatory circuit with reciprocal roles in Candida albicans commensalism and pathogenesis. Cell Host Microbe. 2011; 10(2): 118-35.
[102]. Chen C, Noble SM. Post-transcriptional regulation of the Sef1 transcription factor controls the virulence of Candida albicans in its mammalian host. PLoS Pathog. 2012; 8(11): e1002956.
[103]. Riggle PJ, Kumamoto CA. Role of a Candida albicans P1-type ATPase in resistance to copper and silver ion toxicity. J Bacteriol. 2000; 182(17): 4899-905.
[104]. Weissman Z, Berdicevsky I, Cavari BZ, Kornitzer D. The high copper tolerance of Candida albicans is mediated by a P-type ATPase. Proc. Natl Acad Sci USA. 2000; 97(7): 3520-525.
[105]. Alvarez FJ, Douglas LM, Konopka JB. The Sur7 protein resides in punctate membrane subdomains and mediates spatial regulation of cell wall synthesis in Candida albicans. Commun Integr Biol. 2009; 2(2): 76-7.
[106]. Alvarez FJ, Douglas LM, Rosebrock A, Konopka JB. The Sur7 protein regulates plasma membrane organization and prevents intracellular cell wall growth in Candida albicans. Mol Biol Cell. 2008; 19(12): 5214-225.
[107]. Bernardo SM, Lee SA. Candida albicans Sur7 contributes to secretion, biofilm formation, and macrophage killing. BMC Microbiol. 2010; 10: 133.
[108]. Wang HX, Douglas LM, Aimanianda V, Latge JP, Konopka JB. The Candida albicans Sur7 protein is needed for proper synthesis of the fibrillar component of the cell wall that confers strength. Eukaryot Cell 2011; 10(1): 72-80.
[109]. Douglas LM, Wang HX, Keppler-Ross S, Dean N, Konopka JB. Sur7 promotes plasma membrane organization and is needed for resistance to stressful conditions and to the invasive growth and virulence of Candida albicans. MBio 2012; 3(1): 254-11
[110]. Villa S, Hamideh M, Weinstock A, Qasim MN, Hazbun TR, Sellam A, et al. Transcriptional control of hyphal morpho-genesis in Candida albicans. FEMS yeast Res. 2020; 20(1): foaa005.
[111]. Lu Y, Su C, Solis NV, Filler SG, Liu H. Synergistic regulation of hyphal elongation by hypoxia, CO(2), and nutrient conditions controls the virulence of Candida albicans. Cell Host Microbe. 2013; 14(5): 499-509
[112]. Biswas K, Morschhauser J. The Mep2p ammonium permease controls nitrogen starvation- induced filamentous growth in Candida albicans. Mol Microbiol. 2005; 56(3): 649-69.
[113]. Tsao CC, Chen YT, Lan CY. A small G protein Rhb1 and a GTPaseactivating protein Tsc2 involved in nitrogen starvationinduced morphogenesis and cell wall integrity of Candida albicans. Fungal Genet Biol. 2009; 46 (2): 126-36.
[114]. Chen YT, Lin CY, Tsai PW, Yang CY, Hsieh WP, Lan CY. Rhb1 regulates the expression of secreted aspartic protease 2 through the TOR signaling pathway in Candida albicans. Eukaryot Cell 2012; 11(2): 168-82.
[115]. Flanagan PR, Liu NN, Fitzpatrick DJ Hokamp K, Köhler JR, Moran GP. The Candida albicans TOR-Activating GTPases Gtr1 and Rhb1 coregulate starvation responses and biofilm formation. mSphere 2017; 2(6): 477-17.
[116]. Shapiro RS, Uppuluri P, Zaas AK,Collins C, Senn H, Perfect JR et al. Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol. 2009; 19(8): 621-29.[117]. Shapiro RS, Sellam A, Tebbji F, Whiteway M, Nantel A, Cowen LE. Pho85, Pcl1, and Hms1 signaling governs Candida albicans morphogenesis induced by high temperature or Hsp90 compromise. Curr Biol. 2012; 22(6): 461-70.
[118]. Veri AO, Miao Z, Shapiro RS. Tebbji F, O’Meara TR, Kim SH, et al. Tuning Hsf1 levels drives distinct fungalmorphogenetic programs with depletion impairing Hsp90 function and overexpression expanding the target space. PLos Genet. 2018; 14(3): 1007270.